A. Mark Schobel
Chief Innovation and Technology Officer\
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Aquestive Therapeutics, Inc. (AQST) | Chief Innovation and Technology Officer\ | $367,500 | $3,257,284 |
| 2023 | Aquestive Therapeutics, Inc. (AQST) | Chief Innovation and Technology Officer\ | $350,000 | $974,056 |
| 2022 | Aquestive Therapeutics, Inc. (AQST) | Chief Innovation and Technology Officer Keith J. Kendall\ \ Former Chief Executive Officer | $350,000 | $810,019 |
| 2021 | Aquestive Therapeutics, Inc. (AQST) | Chief Innovation and Technology Officer Keith J. Kendall\ \ Former Chief Executive Officer | $350,000 | $939,261 |
Earnings-call appearances
No earnings-call appearances recorded yet.